Immucell (ICCC) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $15.9 million.
- Immucell's Total Liabilities fell 1168.65% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year decrease of 1168.65%. This contributed to the annual value of $17.6 million for FY2024, which is 655.19% down from last year.
- Latest data reveals that Immucell reported Total Liabilities of $15.9 million as of Q3 2025, which was down 1168.65% from $16.9 million recorded in Q2 2025.
- In the past 5 years, Immucell's Total Liabilities ranged from a high of $18.8 million in Q4 2023 and a low of $11.5 million during Q2 2021
- Its 5-year average for Total Liabilities is $15.5 million, with a median of $15.9 million in 2025.
- Per our database at Business Quant, Immucell's Total Liabilities surged by 2993.26% in 2023 and then crashed by 1168.65% in 2025.
- Immucell's Total Liabilities (Quarter) stood at $11.9 million in 2021, then rose by 21.8% to $14.5 million in 2022, then grew by 29.93% to $18.8 million in 2023, then decreased by 6.55% to $17.6 million in 2024, then fell by 9.4% to $15.9 million in 2025.
- Its last three reported values are $15.9 million in Q3 2025, $16.9 million for Q2 2025, and $16.6 million during Q1 2025.